(Q83428460)
Statements
Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up (English)
Cecilia M Roteli-Martins
Paulo Naud
Paola De Borba
Julio C Teixeira
Newton S De Carvalho
Toufik Zahaf
Nervo Sanchez
Brecht Geeraerts
Dominique Descamps
13 February 2012